Effect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetes

Current Medical Research and Opinion

Volumn 23, Issue 2, 2007, Pages 435-442

  Hayes, Risa P ^a   Muchmore, Douglas ^a   Schmitke, Jennifer ^b  

^a ELI LILLY AND COMPANY   (United States)

^b ALKERMES INC   (United States)

Author keywords

Inhaled insulin; Patient; Reported outcomes; Treatment preference; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN GLARGINE; INSULIN LISPRO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG FORMULATION; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SELF REPORT; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADULT; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; PATIENT SATISFACTION; POWDERS; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 33847399770     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X167381     Document Type: Article

References (24)

1. Osterberg L, Blaschke T. Adherence to Medication. N Engl J Med 2005;353:487-97
2. Dickinson D, Wilkie P, Harris M. Taking medicines: concordance is not compliance. BMJ 1999;319:787
3. Weiss M, Britten N. What is concordance? Pharm J 2003;271:493
4. Brooks A. Concordance and empowerment: issues in diabetes and educations. Presented at the 40th Annual Meeting of the European Association for the Study of Diabetes; September 5-9, 2004; Munich, Germany
5. Funnell MM, Anderson RM. Patient empowerment: a look back, a look ahead. Diabetes Educ 2003;29:454-62
6. Glasgow RE, Anderson RM. In diabetes care, moving from compliance to adherence is not enough. Diabetes Care 1999;22:2090-2
7. Anderson RM, Funnell MM. Compliance and adherence are dysfunctional concepts in diabetes care. Diabetes Educ 2000;26:597-604
8. Funnell MM, Anderson RM. MSJAMA: the problem with compliance in diabetes. JAMA 2000;284:1709
9. Hollander PA, Blonde L, Rowe R, et al. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care 2004;27:2356-62
10. Quattrin T, Belanger A, Bohannon NJ, et al. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care 2004;27:2622-7
11. Skyler JS, Weinstock RS, Raskin P, et al. Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects. Diabetes Care 2005;28:1630-5
12. Garg S, Rosenstock J, Silverman BL, et al. Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes. Diabetologia 2006;49:891-9
13. Skyler JS, Cefalu WT, Kourides IA, et al. Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study. Lancet 2001;357:331-5
14. Gerber RA, Cappelleri JC, Kourides IA, Gelfand RA. Treatment satisfaction with inhaled insulin in patients with type 1 diabetes: a randomized controlled trial. Diabetes Care 2001;24:1556-9
15. Senn Stephen. Cross-over Trials in Clinical Research, 2nd edn. Chichester, UK: John Wiley, 2002
16. Ware J. SF-36 Health Survey Manual & Interpretation Guide. Lincoln, Rhode Island: QualityMetric, Inc., 2000
17. Grootenhuis PA, Snoek FJ, Heine RJ, Bouter LM. Development of a type 2 diabetes symptom checklist: a measure of symptom severity. Diabet Med 1994;11:253-61
18. Bradley C. Diabetes Treatment Satisfaction Questionnaire (DTSQ). In: Handbook of Psychology and Diabetes. Chur, Switzerland: Harwood Academic Publishers, 1994:111-32
19. Hayes RP, Muchmore D. The importance and correlates of insulin delivery system attributes in patients with type 1 diabetes. Diabetes 2006;55(Suppl 1):A-97 (Abstract 413-P)
20. Hayes RP, Fitzgerald JT, Muchmore DB. Validation of the Insulin Delivery System Questionnaire (IDSQ) in Patients with Type 1 Diabetes. 2006 International Society for Quality of Life Research meeting abstracts [www.isoqol.org/ 2006mtgabstracts]. The QLR Journal, A-22, Abstract #1229
21. Marshall TS, Silva S, Hayes RP. Validation of the Insulin Delivery System Questionnaire (IDSQ) in patients with type 2 diabetes [abstract]. J Diab Sci Technol 2007. In press
22. Rave KM, Nosek L, de la Pena A, et al. Dose response of inhaled dry powder insulin and dose equivalence to subcutaneous insulin lispro. Diabetes Care 2005;28:2400-5
23. Cappelleri J, Gerber R, Kourides I, Gelfand R. Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes. Diabetes Care 2000:23:1799-803
24. EXUBERA® (insulin human [rDNA origin]) Inhalation Powder, [article online]. Available at http://www.nektar.com/wt/page/exubera. Accessed July 18, 2006